Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -1.637\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CCOc1cc(C(=O)NCc2ccc(C)cc2)ccc1OCC(=O)N1CCOCC1
(b) Cc1cccc(N(C)S(=O)(=O)c2ccc3c(c2)NC(=O)CC(=O)N3)c1
(c) CCN(C(=O)COC(=O)CNS(=O)(=O)c1ccc2ccccc2c1)C1CCCCC1
(d) CCCCOC(=O)C1=C(N)OC2=C(C(=O)CCC2)[C@]12C(=O)Nc1ccccc12
(e) Cc1ccnc(SCC(=O)N2CCCc3ccccc32)n1
Answer: e. Cc1ccnc(SCC(=O)N2CCCc3ccccc32)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccnc(SCC(=O)N2CCCc3ccccc32)n1
Cc1ccnc(SCC(=O)N2CCCc3ccccc32)n1
1-(3,4-dihydro-2H-quinolin-1-yl)-2-(4-methylpyrimidin-2-yl)sulfanylethanone